Job Watch

Notice of Special Interest (NOSI) in Migraine and Headache Research

Notice NOT-NS-22-051 from the NIH Guide for Grants and Contracts

Wellcome Sanger Institute: Senior Bioinformatician

New Scientist - Bioinformatics - Thu, 2021-12-23 18:59
£37,865-£45,359 per annum: Wellcome Sanger Institute:   Open Targets has launched Open Targets Genetics (https://genetics.opentargets.org), a portal that aggregates large scale GWAS data with functiona... Cambridge, Cambridgeshire (GB)
Categories: Job Watch

Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)

Funding Opportunity RFA-MH-22-136 from the NIH Guide for Grants and Contracts. This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) and suicide in late-life. Emphasis is placed on research that identifies neurobiological and environmental mechanisms associated with social isolation and loneliness that increase risk for suicidal thoughts and behavior in late-life, that uses an experimental therapeutics approach to identify targets and develop and test interventions to prevent late-life suicide, and that develops new and modifies existing service delivery models to enhance social connection in late-life to prevent suicide.

Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)

Funding Opportunity RFA-MH-22-135 from the NIH Guide for Grants and Contracts. This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) and suicide in late-life. Emphasis is placed on research that identifies neurobiological and environmental mechanisms associated with social isolation and loneliness that increase risk for suicidal thoughts and behavior in late-life, that uses an experimental therapeutics approach to identify targets and develop and test interventions to prevent late-life suicide, and that develops new and modifies existing service delivery models to enhance social connection in late-life to prevent suicide.

Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)

Funding Opportunity RFA-AI-21-079 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from single institutions or consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The program will support centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy. The overarching goal of the program is to improve the understanding of the pathogenesis of these conditions and to provide a rational foundation for new, effective treatments and prevention strategies.

NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional)

Funding Opportunity PAR-22-077 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) allows for renewal and competing revision applications, and their resubmissions, for funded U54Specialized Centercooperative agreements thatsupportlarge-scale, complex research projects with multiple highly integrated components focused onacommon research question relevant to Alzheimers disease (AD) andAlzheimers disease-related dementias (ADRD).It is anticipated that such projects will likely involve an integrated multidisciplinary team of investigators within a single institution or a consortium ofinstitutions,andwill address one or moreAD/ADRD implementation research milestonessupporting theresearch goals of theNational Plan to Address Alzheimers and Related Dementias.

The Francis Crick Institute: Senior Laboratory Research Scientist

New Scientist - Bioinformatics - Wed, 2021-12-22 04:52
From £35,500, subject to skills and experience.: The Francis Crick Institute: We are looking for a scientist with experience and excellent skills in bioinformatics to undertake a translational project in our lab. London (Central), London (Greater)
Categories: Job Watch

STFC: Computational Scientist

New Scientist - Bioinformatics - Wed, 2021-12-22 04:11
£39,748 to £44,166 (dependent on qualifications and experience): STFC: Applications are encouraged for an enthusiastic person to work in the core CCP4 group at the STFC Rutherford Appleton Laboratory. Didcot, Oxfordshire
Categories: Job Watch

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

Funding Opportunity PAS-22-096 from the NIH Guide for Grants and Contracts. The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Aging (NIA), and the National Heart, Lung, and Blood Institute (NHLBI). Investigator-initiated research project grant applications (R01s) in specific areas of basic and early translational hematology research are invited to this program that supports growth in the nonmalignant hematology research domain. Specific emerging topics that are at the l?e?a?d?i?n?g? ?e?d?g?e? of the field will change over time and will be updated annually through the NIH Guide to Grants and Contracts and hyperlinked to this FOA.

Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)

Funding Opportunity PAR-22-094 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing new tests, animal models, techniques, etc. to advance research on Alzheimer's disease (AD) and its related dementias (ADRD) that need additional preliminary data with broader dissemination to establish them for more general use in this research field. The priority topics will be announced through a series of Notices published subsequent to this FOA.

Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)

Funding Opportunity PAR-22-093 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing research on current topics in Alzheimer's disease (AD) and its related dementias (ADRD). Further information on the high-priority topics of interest will be announced through a series of Notices published subsequent to this FOA.

Notice of Special interest (NOSI): Medications Development for Stimulant Use Disorders

Notice NOT-DA-22-049 from the NIH Guide for Grants and Contracts

Notice of Special Interest: Research on Pain, Pain Management, and Opioids in Aging

Notice NOT-AG-22-004 from the NIH Guide for Grants and Contracts

Pages

Subscribe to Anil Jegga aggregator - Job Watch